Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators

CLEC-2 expression is maintained on activated platelets and on platelet microparticles

(2014) E. Gitz et al.   BLOOD

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial

(2012) Patrick A. Ott et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Constitutive Dimerization of Glycoprotein VI (GPVI) in Resting Platelets Is Essential for Binding to Collagen and Activation in Flowing Blood

(2012) Stephanie M. Jung et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways

(2012) J. F. ARTHUR et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles

(2012) Eva van Rooij et al.   NATURE REVIEWS DRUG DISCOVERY

Pharmacokinetic evaluation of oblimersen sodium for the treatment of chronic lymphocytic leukemia

(2011) Pooja P Advani et al.   Expert Opinion on Drug Metabolism & Toxicology

Chemical modification and design of anti-miRNA oligonucleotides

(2011) K A Lennox et al.   GENE THERAPY

The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction

(2011) L. D. TAPP et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

GPVI and GPIbα Mediate Staphylococcal Superantigen-Like Protein 5 (SSL5) Induced Platelet Activation and Direct toward Glycans as Potential Inhibitors

(2011) Houyuan Hu et al.   PLoS One

Platelets and innate immunity

(2009) John W. Semple et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcγRIIa and induce GPVI ectodomain shedding

(2009) Mohammad Al-Tamimi et al.   PLATELETS